Hung‐Yuan Li
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 31
- Diabetes Management and Research 14
- Obstetrics and Gynecology top 2%
- Gestational Diabetes Research and Management 20
- Pregnancy and preeclampsia studies 18
- Epidemiology top 5%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 14
-
- Metabolism, Diabetes, and Cancer 15
- Microbial metabolism and enzyme function 15
-
- Birth, Development, and Health 13
- Co-authors
- Lee‐Ming ChuangMao‐Shin LinShyang‐Rong ShihJung‐Nan WeiTien‐Jyun ChangHsien‐Li KaoPi‐Hua LiuCheng-Hsin Lin
- Cited by
- Endocrinology, Diabetes and MetabolismObstetrics and GynecologyCardiology and Cardiovascular Medicine
- Journals
- Diabetes Research and Clinical Practice (8 papers)Journal of Diabetes Investigation (8 papers)The Journal of Clinical Endocrinology & Metabolism (7 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Hung‐Yuan Li
165 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 141
- Endocrinology, Diabetes and Metabolism 759
- Obstetrics and Gynecology 314
- Cardiology and Cardiovascular Medicine 411
- Epidemiology 570
- Cancer Research 230
Countries citing papers authored by Hung‐Yuan Li
This map shows the geographic impact of Hung‐Yuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Yuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Yuan Li more than expected).
Fields of papers citing papers by Hung‐Yuan Li
This network shows the impact of papers produced by Hung‐Yuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Yuan Li. The network helps show where Hung‐Yuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hung‐Yuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 6 | |
| 7 | Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer | 2020 | 1 |
| 8 | Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma | 2020 | 1 |
| 9 | miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer | 2020 | 6 |
| 10 | LncRNA SNHG16 Promotes the Progression of Laryngeal Squamous Cell Carcinoma by Mediating miR-877-5p/FOXP4 Axis | 2020 | 2 |
| 11 | Regulatory Networks of LncRNA MALAT-1 in Cancer | 2020 | 5 |
| 12 | Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation | 2020 | 1 |
| 13 | LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis | 2020 | 1 |
| 14 | Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma | 2019 | 1 |
| 15 | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas | 2018 | 7 |
| 16 | Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer | 2017 | 4 |
| 17 | Dysregulated pathways in type 2 diabetes mellitus | 2017 | 3 |
| 18 | MicroRNA-142 promotes the expression of eNOS in human peripheral blood-derived endothelial progenitor cells in vitro. | 2016 | 7 |
| 19 | 2014 | 10 | |
| 20 | 2006 | 6 |
About Hung‐Yuan Li
Hung‐Yuan Li is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Cancer Research, having authored 175 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Gestational Diabetes Research and Management (20 papers), Pregnancy and preeclampsia studies (18 papers), Metabolism, Diabetes, and Cancer (15 papers), Microbial metabolism and enzyme function (15 papers), Diabetes Management and Research (14 papers), Cancer-related molecular mechanisms research (14 papers) and Birth, Development, and Health (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (759 citations), Obstetrics and Gynecology (314 citations) and Cardiology and Cardiovascular Medicine (411 citations). Hung‐Yuan Li has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Lee‐Ming Chuang, Mao‐Shin Lin, Shyang‐Rong Shih, Jung‐Nan Wei, Tien‐Jyun Chang, Hsien‐Li Kao, Pi‐Hua Liu, Cheng-Hsin Lin, Shu‐Huei Wang and Mao-Shin Lin. Their work appears in journals such as Diabetes Research and Clinical Practice, Journal of Diabetes Investigation, The Journal of Clinical Endocrinology & Metabolism, PLoS ONE and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.